QA: ENDONOVO THERAPEUTICS INC. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001528172_2022_ENDONOVO_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001528172')"}

Graph

Absolute values for 0001528172, ENDONOVO THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 94,855
1 IntangibleAssetsNetIncludingGoodwill 1,912,356
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 17,701,710
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 79,825
7 CostOfGoodsAndServicesSold 14,985
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 2,284,667
11 remainder_Revenues 73,105
12 remainder_NetIncome -878,347
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,007,211
1 Liabilities 17,781,535
2 Expenses 2,299,652
3 Revenues 73,105
4 StockholdersEquity -15,774,324
5 NetIncome -3,104,894
6 ComprehensiveNetIncome -3,104,894
7 BaseVar 11,519,925
8 EconomicCapitalRatio -3.06

Edgar->Model Mapping

Feature Distribution

Change over Time